Skip to main content
NVDA+0.72%AAPL-0.44%MSFT-0.85%GOOGL-1.06%AMZN+0.39%TSM+1.40%SPCX-0.40%META-0.23%AVGO+2.33%TSLA+1.03%LLY+0.45%BRK-B+1.17%MU+2.34%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.29%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.11%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.80%NVS+1.78%NZDMXN+0.60%USDJPY+0.58%NZDJPY+0.58%EURNZD-0.53%AUDJPY+0.52%EURUSD-0.52%AUDDKK+0.47%NZDCHF+0.47%USDCHF+0.46%CADJPY+0.46%EURAUD-0.45%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.41%GBPNZD-0.40%EURCAD-0.37%NZDSGD+0.36%GBPAUD-0.35%EURSEK-0.34%CADCHF+0.33%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.30%GBPCAD-0.29%GBPMXN-0.28%EURHKD-0.28%USDDKK+0.27%USDMXN+0.27%EURNOK-0.24%EURSGD-0.24%AUDSGD+0.23%AUDNOK+0.22%CHFSEK-0.21%USDTRY+0.18%USDILS+0.16%GBPJPY+0.16%NOKJPY+0.15%GBPSGD-0.15%USDZAR+0.14%SGDJPY+0.14%PLNJPY-0.14%USDCAD+0.13%EURZAR-0.13%CHFJPY+0.13%NZDCAD+0.12%CHFNOK-0.11%EURGBP-0.10%CHFSGD-0.10%USDSEK-0.07%AUDNZD-0.07%EURJPY+0.07%EURCHF-0.07%AUDUSD-0.06%AUDCAD+0.06%USDTHB-0.06%EURPLN+0.04%GBPZAR-0.04%GBPCHF+0.04%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDNOK+0.03%USDCNH-0.02%EURCZK0.00%EURDKK0.00%NZDUSD0.00%COFFEE-1.76%XPTUSD-1.59%GAGUSD-1.23%XAGUSD-1.23%HG1+1.17%SUGAR+0.92%XNGUSD+0.75%S1+0.48%UKOIL-0.41%COCOA+0.31%USOIL-0.25%W1+0.25%BTCUSD-0.14%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.60%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT+0.05%XLMUSD-0.69%UNIUSD-1.61%LTCUSD+17.89%SUIUSD-0.56%HBARUSDT-1.92%TONUSD+41.71%TAOUSDT-1.22%AAVEUSD-3.15%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.78%WLDUSDT-0.78%ARBUSDT-1.00%JUPUSDT-1.50%INJUSDT-2.90%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-3.99%PYTHUSDT-3.58%FETUSDT-0.37%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-2.00%OPUSDT-1.09%IOTAUSDT+0.31%WIFUSDT-1.72%POLUSDT-1.83%AXSUSDT-0.90%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.42%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%NVDA+0.72%AAPL-0.44%MSFT-0.85%GOOGL-1.06%AMZN+0.39%TSM+1.40%SPCX-0.40%META-0.23%AVGO+2.33%TSLA+1.03%LLY+0.45%BRK-B+1.17%MU+2.34%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.29%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.11%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.80%NVS+1.78%NZDMXN+0.60%USDJPY+0.58%NZDJPY+0.58%EURNZD-0.53%AUDJPY+0.52%EURUSD-0.52%AUDDKK+0.47%NZDCHF+0.47%USDCHF+0.46%CADJPY+0.46%EURAUD-0.45%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.41%GBPNZD-0.40%EURCAD-0.37%NZDSGD+0.36%GBPAUD-0.35%EURSEK-0.34%CADCHF+0.33%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.30%GBPCAD-0.29%GBPMXN-0.28%EURHKD-0.28%USDDKK+0.27%USDMXN+0.27%EURNOK-0.24%EURSGD-0.24%AUDSGD+0.23%AUDNOK+0.22%CHFSEK-0.21%USDTRY+0.18%USDILS+0.16%GBPJPY+0.16%NOKJPY+0.15%GBPSGD-0.15%USDZAR+0.14%SGDJPY+0.14%PLNJPY-0.14%USDCAD+0.13%EURZAR-0.13%CHFJPY+0.13%NZDCAD+0.12%CHFNOK-0.11%EURGBP-0.10%CHFSGD-0.10%USDSEK-0.07%AUDNZD-0.07%EURJPY+0.07%EURCHF-0.07%AUDUSD-0.06%AUDCAD+0.06%USDTHB-0.06%EURPLN+0.04%GBPZAR-0.04%GBPCHF+0.04%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDNOK+0.03%USDCNH-0.02%EURCZK0.00%EURDKK0.00%NZDUSD0.00%COFFEE-1.76%XPTUSD-1.59%GAGUSD-1.23%XAGUSD-1.23%HG1+1.17%SUGAR+0.92%XNGUSD+0.75%S1+0.48%UKOIL-0.41%COCOA+0.31%USOIL-0.25%W1+0.25%BTCUSD-0.14%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.60%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT+0.05%XLMUSD-0.69%UNIUSD-1.61%LTCUSD+17.89%SUIUSD-0.56%HBARUSDT-1.92%TONUSD+41.71%TAOUSDT-1.22%AAVEUSD-3.15%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.78%WLDUSDT-0.78%ARBUSDT-1.00%JUPUSDT-1.50%INJUSDT-2.90%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-3.99%PYTHUSDT-3.58%FETUSDT-0.37%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-2.00%OPUSDT-1.09%IOTAUSDT+0.31%WIFUSDT-1.72%POLUSDT-1.83%AXSUSDT-0.90%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.42%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%
MK

Merck KGaA (MRKd)

FRA • Healthcare

€143.32
-€0.27 (-0.2%)
Market open

October 27, 2026 at 12:02 UTC

Open€143.2
Previous Close€143.6
Day Range€142.9 - €144.4
Avg. Volume (3M)270.5K
Market Cap€62.3B
P/E Ratio26.3
52 Week Range
€100.7€148.8

Interactive Chart

12:02:44 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned€5.4B100%
Gross Profitminus cost of goods€3.1B58%
Operating Incomeminus R&D and overhead€1.1B22%
Net Incomeminus taxes and the rest€490M9%

In plain terms: out of every €100 in revenue, Merck KGaA keeps €9 as net profit.

Fundamentals & Financials

Revenue (TTM)
€21.1B
Net Income (TTM)
€2.3B
EPS (TTM)
€5.45
ROA (TTM)
4.5%
Current Ratio
1.69
Dividend Yield
1.6%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

€1.08Q2 2019
€0.79Q3 2019
€0.73Q4 2019

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2019

Merck KGaA topped consensus on both EPS and revenue in the second fiscal quarter of 2026, reported Aug. 6, with adjusted EPS of EUR 2.14 against a EUR 2.00 estimate, +7.0%, and revenue of EUR 5.434 billion against a EUR 5.290 billion estimate, +2.7%. Revenue rose about 3% from EUR 5.255 billion a year ago, while gross margin came in near 58% and operating margin around 22% as operating income reached about EUR 1.2 billion. Net income fell about 25% to roughly EUR 490 million from EUR 652 million a year earlier, and operating cash flow was about EUR 605 million. Consensus for the next period calls for EPS of EUR 2.07 on revenue of EUR 5.383 billion.

Next report — what to expect

Merck KGaA (MRK.DE) reports earnings on November 12, 2026. Consensus expectations call for EPS of EUR 2.04 on revenue of EUR 5.40 billion. For trailing context, revenue rose +3.4% year over year last quarter. Merck KGaA has beaten EPS in 4 of 8 most recent quarters.

View full earnings history

About Merck KGaA

Merck KGaA trades on XETRA under MRK.DE and operates as a healthcare company with prescription medicines at its core, alongside laboratory and industrial supplies and electronic materials. In FY2025, it generated EUR 21.1 billion in revenue. The company is a subsidiary of E. Merck KG.

Name
Merck KGaA
CEO
Kai Beckmann
Website
www.merckgroup.com
Industry
Healthcare
Year Founded
1668
Employees
62,136

Today's Snapshot

AI-generated

MRKd is slightly lower at 143.55 so far today, in line with a flat sector. MRKd is trading within 3.5% of its 52-week high of 148.80. Merck KGaA said pimicotinib, a rare joint-tumor drug, showed sustained benefits.

Trading Volume

Below 10d avg (254.1K)

29.3K

vs S&P 500 Today

Underperforming Market

-0.73%

Updated: October 27, 2026 at 11:38 UTC

MRKd Headlines

Merck KGaA to buy Silence Therapeutics in cash deal

October 19, 2026

3 min read

Merck KGaA to buy Bio-Techne for $11.3 billion

June 25, 2026

3 min read

AI Stock Bubble Concerns Trigger Broad Market Sell-Off

November 18, 2025

5 min read
View All News

Technical Indicators

6 Buy2 Neutral0 Sell
MRKd registers as Strong Buy on a technically constructive setup where price sits above short, medium and long moving averages and the MACD and momentum readings are positive. ADX is moderate at 23.69, indicating a developing trend rather than a weak one, while RSI and other oscillators are neutral to mildly supportive. ATR is moderate and intraday volatility is contained, and OBV is strongly positive, reflecting accumulation. The classic pivot aligns close to the current price, offering a nearby reference. Technical takeaway: Strong Buy based on multi‑period moving average support, positive momentum and healthy volume.
All signals
  • EMA (5 indicators)$129.70 - $143.09
    Buy
  • RSI (14)57.13
    Neutral
  • Stochastic %K (14, 3, 3)66.94
    Neutral
  • MACD Level (12, 26)2.21
    Buy

Peers & Related Assets

BAYNdBayer Aktiengesellschaft
€44.94-1.4%
600276.SSJiangsu Hengrui Medicine Co., Ltd.
6MK.DEMerck & Co., Inc.
GSK.LGSK plc
GALD.SWGalderma Group AG
BAYN.DEBayer Aktiengesellschaft
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.